Literature DB >> 28254797

Pas de Deux: Glucagon and Thyroid Hormone Moving in Perfect Synchrony.

Alexandra L Ghaben1, Philipp E Scherer2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28254797      PMCID： PMC5338644          DOI： 10.1161/CIRCRESAHA.117.310452

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  11 in total

1.  Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease.

Authors:  J Pekkanen; S Linn; G Heiss; C M Suchindran; A Leon; B M Rifkind; H A Tyroler
Journal:  N Engl J Med       Date:  1990-06-14       Impact factor: 91.245

Review 2.  Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity.

Authors:  Roger H Unger; Philipp E Scherer
Journal:  Trends Endocrinol Metab       Date:  2010-03-10       Impact factor: 12.015

3.  Metabolic syndrome and risk of cardiovascular disease: a meta-analysis.

Authors:  Andrea Galassi; Kristi Reynolds; Jiang He
Journal:  Am J Med       Date:  2006-10       Impact factor: 4.965

4.  Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease.

Authors:  Brian Finan; Christoffer Clemmensen; Zhimeng Zhu; Kerstin Stemmer; Karine Gauthier; Luisa Müller; Meri De Angelis; Kristin Moreth; Frauke Neff; Diego Perez-Tilve; Katrin Fischer; Dominik Lutter; Miguel A Sánchez-Garrido; Peng Liu; Jan Tuckermann; Mohsen Malehmir; Marc E Healy; Achim Weber; Mathias Heikenwalder; Martin Jastroch; Maximilian Kleinert; Sigrid Jall; Sara Brandt; Frédéric Flamant; Karl-Werner Schramm; Heike Biebermann; Yvonne Döring; Christian Weber; Kirk M Habegger; Michaela Keuper; Vasily Gelfanov; Fa Liu; Josef Köhrle; Jan Rozman; Helmut Fuchs; Valerie Gailus-Durner; Martin Hrabě de Angelis; Susanna M Hofmann; Bin Yang; Matthias H Tschöp; Richard DiMarchi; Timo D Müller
Journal:  Cell       Date:  2016-10-06       Impact factor: 41.582

Review 5.  The role of thyroid hormone and brown adipose tissue in energy homoeostasis.

Authors:  Antonio C Bianco; Elizabeth A McAninch
Journal:  Lancet Diabetes Endocrinol       Date:  2013-10-18       Impact factor: 32.069

Review 6.  Thyroid hormones and cardiovascular disease.

Authors:  Avais Jabbar; Alessandro Pingitore; Simon H S Pearce; Azfar Zaman; Giorgio Iervasi; Salman Razvi
Journal:  Nat Rev Cardiol       Date:  2016-11-04       Impact factor: 32.419

7.  Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies.

Authors:  Christof M Kazda; Ying Ding; Ronan P Kelly; Parag Garhyan; Chunxue Shi; Chay Ngee Lim; Haoda Fu; David E Watson; Andrew J Lewin; William H Landschulz; Mark A Deeg; David E Moller; Thomas A Hardy
Journal:  Diabetes Care       Date:  2015-12-17       Impact factor: 17.152

Review 8.  Clinical efficacy and safety of statins in managing cardiovascular risk.

Authors:  Navin K Kapur; Kiran Musunuru
Journal:  Vasc Health Risk Manag       Date:  2008

Review 9.  Thyroid Hormone Mimetics: the Past, Current Status and Future Challenges.

Authors:  L P B Elbers; J J P Kastelein; B Sjouke
Journal:  Curr Atheroscler Rep       Date:  2016-03       Impact factor: 5.113

10.  Clinical Trials, Triumphs, and Tribulations of Glucagon Receptor Antagonists.

Authors:  Mackenzie J Pearson; Roger H Unger; William L Holland
Journal:  Diabetes Care       Date:  2016-07       Impact factor: 19.112
View more
  1 in total

Review 1.  The Confluence of Innovation in Therapeutics and Regulation: Recent CMC Considerations.

Authors:  Lucas Gutierrez; Nina S Cauchon; Twinkle R Christian; Michael J Giffin; Michael J Abernathy
Journal:  J Pharm Sci       Date:  2020-09-21       Impact factor: 3.534
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.